| Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project M Federico, M Bellei, L Marcheselli, S Luminari, A Lopez-Guillermo, ... Journal of Clinical Oncology 27 (27), 4555-4562, 2009 | 859 | 2009 |
| The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts P Ferri, M Guadi, L Marcheselli, S Balduzzi, D Magnani, R Di Lorenzo Risk management and healthcare policy, 203-211, 2016 | 487 | 2016 |
| ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin’s lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei … M Federico, S Luminari, E Iannitto, G Polimeno, L Marcheselli, ... J Clin Oncol 27 (5), 805-811, 2009 | 375 | 2009 |
| R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana … M Federico, S Luminari, A Dondi, A Tucci, U Vitolo, L Rigacci, ... Journal of Clinical Oncology 31 (12), 1506-1513, 2013 | 320 | 2013 |
| Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study C Mucciarini, G Rossi, F Bertolini, R Valli, C Cirilli, I Rashid, L Marcheselli, ... BMC cancer 7, 1-7, 2007 | 278 | 2007 |
| Empathy and burnout: an analytic cross-sectional study among nurses and nursing students P Ferri, E Guerra, L Marcheselli, L Cunico, R Di Lorenzo Acta Bio-Medica De L'ateneo Parmense 86 (Supplemento 2), 104-115, 2015 | 176 | 2015 |
| Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies J Trotman, S Luminari, S Boussetta, A Versari, J Dupuis, C Tychyj, ... The Lancet Haematology 1 (1), e17-e27, 2014 | 169 | 2014 |
| Watchful waiting in low–tumor burden follicular lymphoma in the rituximab era: results of an F2-study database P Solal-Céligny, M Bellei, L Marcheselli, EA Pesce, S Pileri, P McLaughlin, ... Journal of clinical oncology 30 (31), 3848-3853, 2012 | 152 | 2012 |
| Long-term results of the FOLL05 trial comparing R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular lymphoma S Luminari, A Ferrari, M Manni, A Dondi, A Chiarenza, F Merli, C Rusconi, ... Journal of Clinical Oncology 36 (7), 689-698, 2018 | 136 | 2018 |
| Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study S Sacchi, L Marcheselli, A Bari, R Marcheselli, S Pozzi, S Luminari, ... Haematologica 93 (3), 398-404, 2008 | 129 | 2008 |
| Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story A Bari, L Marcheselli, S Sacchi, R Marcheselli, S Pozzi, P Ferri, E Balleari, ... Annals of Oncology 21 (7), 1486-1491, 2010 | 120 | 2010 |
| Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial S Galimberti, S Luminari, E Ciabatti, S Grassi, F Guerrini, A Dondi, ... Clinical Cancer Research 20 (24), 6398-6405, 2014 | 117 | 2014 |
| Long-term results of the HD2000 trial comparing ABVD versus BEACOPP versus COPP-EBV-CAD in untreated patients with advanced Hodgkin lymphoma: a study by Fondazione Italiana Linfomi F Merli, S Luminari, PG Gobbi, N Cascavilla, C Mammi, F Ilariucci, ... J Clin Oncol 34 (11), 1175-1181, 2016 | 116 | 2016 |
| The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project M Bellei, FM Foss, AR Shustov, SM Horwitz, L Marcheselli, WS Kim, ... Haematologica 103 (7), 1191, 2018 | 108 | 2018 |
| Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis M Federico, MDC Barrigón, L Marcheselli, V Tarantino, M Manni, ... The Lancet Haematology 5 (8), e359-e367, 2018 | 105 | 2018 |
| Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population‐based analysis S Pozzi, L Marcheselli, A Bari, EV Liardo, R Marcheselli, S Luminari, ... British journal of haematology 163 (1), 40-46, 2013 | 102 | 2013 |
| Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the Fondazione Italiana Linfomi F Merli, S Luminari, A Tucci, A Arcari, L Rigacci, E Hawkes, CS Chiattone, ... Journal of clinical oncology 39 (11), 1214-1222, 2021 | 101 | 2021 |
| Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis M Pirani, R Marcheselli, L Marcheselli, A Bari, M Federico, S Sacchi Annals of Oncology 22 (8), 1845-1858, 2011 | 96 | 2011 |
| Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre-and post … T Tadmor, A Bari, S Sacchi, L Marcheselli, EV Liardo, I Avivi, N Benyamini, ... haematologica 99 (1), 125, 2014 | 95 | 2014 |
| Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas S Luminari, M Cesaretti, L Marcheselli, I Rashid, S Madrigali, A Maiorana, ... Annals of oncology 21 (4), 855-859, 2010 | 86 | 2010 |
